IL6 and head and neck squamous cell carcinoma: IL-6 overexpression in patients with HNSCC is associated with poor prognosis, probably by enabling an immunosuppressive TME by increasing the presence of myeloid-derived suppressor cells and PDL-1 expression, and is considered a significant predictor of treatment outcome [90].